chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 10.0
Sex: F
Vaccine: HEPA, HPV9, IPV, TDAP
Symptoms: Blood glucose, Depressed level of consciousness, Dizziness, Headache, Hyporesponsive to stimuli
Clinical narrative: Patient received injections, told patient and mother to wait in room with door open for 15 mins after receiving injections due to possible  vasovagal response. After about five minutes front office staff member came and got medical assistant stating that mother left room and alerted staff member that patient was complaining of sudden onset of severe headache and feeling lightheaded and dizzy. Upon MA entering the room found patient laying back on exam table unconscious and unresponsive. Gave a hard sternum rub at that time and patient became partially responsive. At this time MD entered room and vitals were obtained. Patient answering questions however still lethargic and not fully alert. EMS was called at this time and patient was transport to local hospital for further evaluation.
Age: 10.0
Sex: F
Vaccine: HEPA, HPV9, IPV, TDAP
Symptoms: Lethargy, Loss of consciousness, Unresponsive to stimuli
Clinical narrative: Patient received injections, told patient and mother to wait in room with door open for 15 mins after receiving injections due to possible  vasovagal response. After about five minutes front office staff member came and got medical assistant stating that mother left room and alerted staff member that patient was complaining of sudden onset of severe headache and feeling lightheaded and dizzy. Upon MA entering the room found patient laying back on exam table unconscious and unresponsive. Gave a hard sternum rub at that time and patient became partially responsive. At this time MD entered room and vitals were obtained. Patient answering questions however still lethargic and not fully alert. EMS was called at this time and patient was transport to local hospital for further evaluation.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Adrenal disorder, Angiogram pulmonary abnormal, COVID-19, Central nervous system lesion
Clinical narrative: Patient is a 65 y.o. female with a history of Stage 4 Squamous NSCLC of RLL with Peripheral Neuropathy, Chronic Hypoxic Respiratory Failure (1L oxygen), NIDDM2, Depression who presented to Hospital 11/29/2022 with several days of cough and sore throat, myalgias after recent COVID exposure. She was found to have acute on chronic hypoxemic respiratory failure and positive for SARS-CoV-2 and influenza A. Hospital course was complicated by finding of new brain mass and suspected progression of metastatic disease. No plan for surgical intervention. RadOnc plans for outpatient stereotactic radiation starting 12/9/22. Hospital course prolonged due to need for continued treatment of COVID/influenza and glycemic control. Patient was placed on insulin gtt on 12/5 with Endocrinology consult placed. Insulin gtt was then discontinued on 12/7/22 and transitioned to subcutaneous insulin regimen.   1. Acute on Chronic Hypoxemic Respiratory Failure, resolved Chronically on 1-2L via NC but required 5L NC in ED. Secondary to COVID and influenza A infection. CTPA 11/30/22: consolidation in right perihilar region consistent with post treatment changes and underlying pneumonia, no PE, progression of mediastinal adenopathy. Patient has returned to  2. Steroid-Induced Hyperglycemia, NIDDM2: A1c 12.8% on 10/14/2021, A1c 10.7% on admit. Home oral medications held. DM Educator consulted, met with patient and family on 12/5, will meet with them again prior to discharge. Patient required insulin gtt on 12/5, transitioned off on 12/7. Transitioned to Lantus 55 units nightly, lispro 55 units TID before meals. Resume metformin on discharge and discontinue all other home diabetes medications. Will need close follow up with PCP as outpatient. 3. New Brain Lesion: CT Head 11/30/22: new 1.8cm hypodense right frontal lobe lesion with vasogenic edema. MRI confirmed. Neurosurgery following with no plan for intervention. RadOnc mapping on 12/2 with outpatient follow up for radiation. Dexamethasone 4mg QID then 4mg TID (12/3-12/6) then 4mg BID until RadOnc follow up on 12/9 who will manage the remaining taper. 4. Adrenal Lesion: Incidentally seen on CT. Oncology follow up outpatient. Oncology Navigator consulted.  5. Stage IV Lung Cancer: Follows with Dr (Rad Onc), Dr. and Dr. (Onc). Diagnosed in 07/2020 on Taxol/Carboplatin prior to admission (missed dose due 11/23/22). Oncology followed, f/u per above.  6. Normocytic Anemia: Likely secondary to chemo medications. Hbg 9.5 on admit, baseline ~10. 9.5 on admit. Carboplatin nadir 28 days. Taxol nadir 15-21 days. Last chemo infusion 11/03. 7. Thrombocytopenia: Likely secondary to chemo medications. Continue to monitor clinically. 8. Hypothyroidism: Secondary to Keytruda use in past. Decreased levothyroxine to 150 mcg daily per Endocrinology recommendations, recommend repeat TSH and free T4 in 4 weeks. 9. Chronic Right-sided Vision Changes: Ongoing for months, possibly related to brain lesion. Encouraged outpatient Ophtho follow up.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram head abnormal, Cough, Exposure to SARS-CoV-2, Glycosylated haemoglobin increased, Haemoglobin decreased
Clinical narrative: Patient is a 65 y.o. female with a history of Stage 4 Squamous NSCLC of RLL with Peripheral Neuropathy, Chronic Hypoxic Respiratory Failure (1L oxygen), NIDDM2, Depression who presented to Hospital 11/29/2022 with several days of cough and sore throat, myalgias after recent COVID exposure. She was found to have acute on chronic hypoxemic respiratory failure and positive for SARS-CoV-2 and influenza A. Hospital course was complicated by finding of new brain mass and suspected progression of metastatic disease. No plan for surgical intervention. RadOnc plans for outpatient stereotactic radiation starting 12/9/22. Hospital course prolonged due to need for continued treatment of COVID/influenza and glycemic control. Patient was placed on insulin gtt on 12/5 with Endocrinology consult placed. Insulin gtt was then discontinued on 12/7/22 and transitioned to subcutaneous insulin regimen.   1. Acute on Chronic Hypoxemic Respiratory Failure, resolved Chronically on 1-2L via NC but required 5L NC in ED. Secondary to COVID and influenza A infection. CTPA 11/30/22: consolidation in right perihilar region consistent with post treatment changes and underlying pneumonia, no PE, progression of mediastinal adenopathy. Patient has returned to  2. Steroid-Induced Hyperglycemia, NIDDM2: A1c 12.8% on 10/14/2021, A1c 10.7% on admit. Home oral medications held. DM Educator consulted, met with patient and family on 12/5, will meet with them again prior to discharge. Patient required insulin gtt on 12/5, transitioned off on 12/7. Transitioned to Lantus 55 units nightly, lispro 55 units TID before meals. Resume metformin on discharge and discontinue all other home diabetes medications. Will need close follow up with PCP as outpatient. 3. New Brain Lesion: CT Head 11/30/22: new 1.8cm hypodense right frontal lobe lesion with vasogenic edema. MRI confirmed. Neurosurgery following with no plan for intervention. RadOnc mapping on 12/2 with outpatient follow up for radiation. Dexamethasone 4mg QID then 4mg TID (12/3-12/6) then 4mg BID until RadOnc follow up on 12/9 who will manage the remaining taper. 4. Adrenal Lesion: Incidentally seen on CT. Oncology follow up outpatient. Oncology Navigator consulted.  5. Stage IV Lung Cancer: Follows with Dr (Rad Onc), Dr. and Dr. (Onc). Diagnosed in 07/2020 on Taxol/Carboplatin prior to admission (missed dose due 11/23/22). Oncology followed, f/u per above.  6. Normocytic Anemia: Likely secondary to chemo medications. Hbg 9.5 on admit, baseline ~10. 9.5 on admit. Carboplatin nadir 28 days. Taxol nadir 15-21 days. Last chemo infusion 11/03. 7. Thrombocytopenia: Likely secondary to chemo medications. Continue to monitor clinically. 8. Hypothyroidism: Secondary to Keytruda use in past. Decreased levothyroxine to 150 mcg daily per Endocrinology recommendations, recommend repeat TSH and free T4 in 4 weeks. 9. Chronic Right-sided Vision Changes: Ongoing for months, possibly related to brain lesion. Encouraged outpatient Ophtho follow up.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperglycaemia, Hypothyroidism, Influenza, Influenza A virus test positive, Intracranial mass
Clinical narrative: Patient is a 65 y.o. female with a history of Stage 4 Squamous NSCLC of RLL with Peripheral Neuropathy, Chronic Hypoxic Respiratory Failure (1L oxygen), NIDDM2, Depression who presented to Hospital 11/29/2022 with several days of cough and sore throat, myalgias after recent COVID exposure. She was found to have acute on chronic hypoxemic respiratory failure and positive for SARS-CoV-2 and influenza A. Hospital course was complicated by finding of new brain mass and suspected progression of metastatic disease. No plan for surgical intervention. RadOnc plans for outpatient stereotactic radiation starting 12/9/22. Hospital course prolonged due to need for continued treatment of COVID/influenza and glycemic control. Patient was placed on insulin gtt on 12/5 with Endocrinology consult placed. Insulin gtt was then discontinued on 12/7/22 and transitioned to subcutaneous insulin regimen.   1. Acute on Chronic Hypoxemic Respiratory Failure, resolved Chronically on 1-2L via NC but required 5L NC in ED. Secondary to COVID and influenza A infection. CTPA 11/30/22: consolidation in right perihilar region consistent with post treatment changes and underlying pneumonia, no PE, progression of mediastinal adenopathy. Patient has returned to  2. Steroid-Induced Hyperglycemia, NIDDM2: A1c 12.8% on 10/14/2021, A1c 10.7% on admit. Home oral medications held. DM Educator consulted, met with patient and family on 12/5, will meet with them again prior to discharge. Patient required insulin gtt on 12/5, transitioned off on 12/7. Transitioned to Lantus 55 units nightly, lispro 55 units TID before meals. Resume metformin on discharge and discontinue all other home diabetes medications. Will need close follow up with PCP as outpatient. 3. New Brain Lesion: CT Head 11/30/22: new 1.8cm hypodense right frontal lobe lesion with vasogenic edema. MRI confirmed. Neurosurgery following with no plan for intervention. RadOnc mapping on 12/2 with outpatient follow up for radiation. Dexamethasone 4mg QID then 4mg TID (12/3-12/6) then 4mg BID until RadOnc follow up on 12/9 who will manage the remaining taper. 4. Adrenal Lesion: Incidentally seen on CT. Oncology follow up outpatient. Oncology Navigator consulted.  5. Stage IV Lung Cancer: Follows with Dr (Rad Onc), Dr. and Dr. (Onc). Diagnosed in 07/2020 on Taxol/Carboplatin prior to admission (missed dose due 11/23/22). Oncology followed, f/u per above.  6. Normocytic Anemia: Likely secondary to chemo medications. Hbg 9.5 on admit, baseline ~10. 9.5 on admit. Carboplatin nadir 28 days. Taxol nadir 15-21 days. Last chemo infusion 11/03. 7. Thrombocytopenia: Likely secondary to chemo medications. Continue to monitor clinically. 8. Hypothyroidism: Secondary to Keytruda use in past. Decreased levothyroxine to 150 mcg daily per Endocrinology recommendations, recommend repeat TSH and free T4 in 4 weeks. 9. Chronic Right-sided Vision Changes: Ongoing for months, possibly related to brain lesion. Encouraged outpatient Ophtho follow up.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Lung consolidation, Magnetic resonance imaging head abnormal, Metastatic neoplasm, Myalgia, Normocytic anaemia
Clinical narrative: Patient is a 65 y.o. female with a history of Stage 4 Squamous NSCLC of RLL with Peripheral Neuropathy, Chronic Hypoxic Respiratory Failure (1L oxygen), NIDDM2, Depression who presented to Hospital 11/29/2022 with several days of cough and sore throat, myalgias after recent COVID exposure. She was found to have acute on chronic hypoxemic respiratory failure and positive for SARS-CoV-2 and influenza A. Hospital course was complicated by finding of new brain mass and suspected progression of metastatic disease. No plan for surgical intervention. RadOnc plans for outpatient stereotactic radiation starting 12/9/22. Hospital course prolonged due to need for continued treatment of COVID/influenza and glycemic control. Patient was placed on insulin gtt on 12/5 with Endocrinology consult placed. Insulin gtt was then discontinued on 12/7/22 and transitioned to subcutaneous insulin regimen.   1. Acute on Chronic Hypoxemic Respiratory Failure, resolved Chronically on 1-2L via NC but required 5L NC in ED. Secondary to COVID and influenza A infection. CTPA 11/30/22: consolidation in right perihilar region consistent with post treatment changes and underlying pneumonia, no PE, progression of mediastinal adenopathy. Patient has returned to  2. Steroid-Induced Hyperglycemia, NIDDM2: A1c 12.8% on 10/14/2021, A1c 10.7% on admit. Home oral medications held. DM Educator consulted, met with patient and family on 12/5, will meet with them again prior to discharge. Patient required insulin gtt on 12/5, transitioned off on 12/7. Transitioned to Lantus 55 units nightly, lispro 55 units TID before meals. Resume metformin on discharge and discontinue all other home diabetes medications. Will need close follow up with PCP as outpatient. 3. New Brain Lesion: CT Head 11/30/22: new 1.8cm hypodense right frontal lobe lesion with vasogenic edema. MRI confirmed. Neurosurgery following with no plan for intervention. RadOnc mapping on 12/2 with outpatient follow up for radiation. Dexamethasone 4mg QID then 4mg TID (12/3-12/6) then 4mg BID until RadOnc follow up on 12/9 who will manage the remaining taper. 4. Adrenal Lesion: Incidentally seen on CT. Oncology follow up outpatient. Oncology Navigator consulted.  5. Stage IV Lung Cancer: Follows with Dr (Rad Onc), Dr. and Dr. (Onc). Diagnosed in 07/2020 on Taxol/Carboplatin prior to admission (missed dose due 11/23/22). Oncology followed, f/u per above.  6. Normocytic Anemia: Likely secondary to chemo medications. Hbg 9.5 on admit, baseline ~10. 9.5 on admit. Carboplatin nadir 28 days. Taxol nadir 15-21 days. Last chemo infusion 11/03. 7. Thrombocytopenia: Likely secondary to chemo medications. Continue to monitor clinically. 8. Hypothyroidism: Secondary to Keytruda use in past. Decreased levothyroxine to 150 mcg daily per Endocrinology recommendations, recommend repeat TSH and free T4 in 4 weeks. 9. Chronic Right-sided Vision Changes: Ongoing for months, possibly related to brain lesion. Encouraged outpatient Ophtho follow up.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pneumonia, Respiratory failure, SARS-CoV-2 test positive, Thrombocytopenia
Clinical narrative: Patient is a 65 y.o. female with a history of Stage 4 Squamous NSCLC of RLL with Peripheral Neuropathy, Chronic Hypoxic Respiratory Failure (1L oxygen), NIDDM2, Depression who presented to Hospital 11/29/2022 with several days of cough and sore throat, myalgias after recent COVID exposure. She was found to have acute on chronic hypoxemic respiratory failure and positive for SARS-CoV-2 and influenza A. Hospital course was complicated by finding of new brain mass and suspected progression of metastatic disease. No plan for surgical intervention. RadOnc plans for outpatient stereotactic radiation starting 12/9/22. Hospital course prolonged due to need for continued treatment of COVID/influenza and glycemic control. Patient was placed on insulin gtt on 12/5 with Endocrinology consult placed. Insulin gtt was then discontinued on 12/7/22 and transitioned to subcutaneous insulin regimen.   1. Acute on Chronic Hypoxemic Respiratory Failure, resolved Chronically on 1-2L via NC but required 5L NC in ED. Secondary to COVID and influenza A infection. CTPA 11/30/22: consolidation in right perihilar region consistent with post treatment changes and underlying pneumonia, no PE, progression of mediastinal adenopathy. Patient has returned to  2. Steroid-Induced Hyperglycemia, NIDDM2: A1c 12.8% on 10/14/2021, A1c 10.7% on admit. Home oral medications held. DM Educator consulted, met with patient and family on 12/5, will meet with them again prior to discharge. Patient required insulin gtt on 12/5, transitioned off on 12/7. Transitioned to Lantus 55 units nightly, lispro 55 units TID before meals. Resume metformin on discharge and discontinue all other home diabetes medications. Will need close follow up with PCP as outpatient. 3. New Brain Lesion: CT Head 11/30/22: new 1.8cm hypodense right frontal lobe lesion with vasogenic edema. MRI confirmed. Neurosurgery following with no plan for intervention. RadOnc mapping on 12/2 with outpatient follow up for radiation. Dexamethasone 4mg QID then 4mg TID (12/3-12/6) then 4mg BID until RadOnc follow up on 12/9 who will manage the remaining taper. 4. Adrenal Lesion: Incidentally seen on CT. Oncology follow up outpatient. Oncology Navigator consulted.  5. Stage IV Lung Cancer: Follows with Dr (Rad Onc), Dr. and Dr. (Onc). Diagnosed in 07/2020 on Taxol/Carboplatin prior to admission (missed dose due 11/23/22). Oncology followed, f/u per above.  6. Normocytic Anemia: Likely secondary to chemo medications. Hbg 9.5 on admit, baseline ~10. 9.5 on admit. Carboplatin nadir 28 days. Taxol nadir 15-21 days. Last chemo infusion 11/03. 7. Thrombocytopenia: Likely secondary to chemo medications. Continue to monitor clinically. 8. Hypothyroidism: Secondary to Keytruda use in past. Decreased levothyroxine to 150 mcg daily per Endocrinology recommendations, recommend repeat TSH and free T4 in 4 weeks. 9. Chronic Right-sided Vision Changes: Ongoing for months, possibly related to brain lesion. Encouraged outpatient Ophtho follow up.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vasogenic cerebral oedema, Visual impairment
Clinical narrative: Patient is a 65 y.o. female with a history of Stage 4 Squamous NSCLC of RLL with Peripheral Neuropathy, Chronic Hypoxic Respiratory Failure (1L oxygen), NIDDM2, Depression who presented to Hospital 11/29/2022 with several days of cough and sore throat, myalgias after recent COVID exposure. She was found to have acute on chronic hypoxemic respiratory failure and positive for SARS-CoV-2 and influenza A. Hospital course was complicated by finding of new brain mass and suspected progression of metastatic disease. No plan for surgical intervention. RadOnc plans for outpatient stereotactic radiation starting 12/9/22. Hospital course prolonged due to need for continued treatment of COVID/influenza and glycemic control. Patient was placed on insulin gtt on 12/5 with Endocrinology consult placed. Insulin gtt was then discontinued on 12/7/22 and transitioned to subcutaneous insulin regimen.   1. Acute on Chronic Hypoxemic Respiratory Failure, resolved Chronically on 1-2L via NC but required 5L NC in ED. Secondary to COVID and influenza A infection. CTPA 11/30/22: consolidation in right perihilar region consistent with post treatment changes and underlying pneumonia, no PE, progression of mediastinal adenopathy. Patient has returned to  2. Steroid-Induced Hyperglycemia, NIDDM2: A1c 12.8% on 10/14/2021, A1c 10.7% on admit. Home oral medications held. DM Educator consulted, met with patient and family on 12/5, will meet with them again prior to discharge. Patient required insulin gtt on 12/5, transitioned off on 12/7. Transitioned to Lantus 55 units nightly, lispro 55 units TID before meals. Resume metformin on discharge and discontinue all other home diabetes medications. Will need close follow up with PCP as outpatient. 3. New Brain Lesion: CT Head 11/30/22: new 1.8cm hypodense right frontal lobe lesion with vasogenic edema. MRI confirmed. Neurosurgery following with no plan for intervention. RadOnc mapping on 12/2 with outpatient follow up for radiation. Dexamethasone 4mg QID then 4mg TID (12/3-12/6) then 4mg BID until RadOnc follow up on 12/9 who will manage the remaining taper. 4. Adrenal Lesion: Incidentally seen on CT. Oncology follow up outpatient. Oncology Navigator consulted.  5. Stage IV Lung Cancer: Follows with Dr (Rad Onc), Dr. and Dr. (Onc). Diagnosed in 07/2020 on Taxol/Carboplatin prior to admission (missed dose due 11/23/22). Oncology followed, f/u per above.  6. Normocytic Anemia: Likely secondary to chemo medications. Hbg 9.5 on admit, baseline ~10. 9.5 on admit. Carboplatin nadir 28 days. Taxol nadir 15-21 days. Last chemo infusion 11/03. 7. Thrombocytopenia: Likely secondary to chemo medications. Continue to monitor clinically. 8. Hypothyroidism: Secondary to Keytruda use in past. Decreased levothyroxine to 150 mcg daily per Endocrinology recommendations, recommend repeat TSH and free T4 in 4 weeks. 9. Chronic Right-sided Vision Changes: Ongoing for months, possibly related to brain lesion. Encouraged outpatient Ophtho follow up.
Age: 82.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthralgia, Erythema, Mass, Ultrasound Doppler abnormal, Venous thrombosis limb
Clinical narrative: I woke up with a pain on the inside of my right knee and there was a little lump there. When I got up in the morning, it was red. I thought it might be a blood clot. I did go to the emergency room and they confirmed it was a blood clot. They said I could go see the doctor at the vascular clinic. I did go there and they did another ultrasound and they said there were two blood clots and they had not moved. They were in a small vein in the leg. They advised to wrap up the leg, elevate it, and apply heat to it.
Age: 7.0
Sex: M
Vaccine: COVID19-2
Symptoms: Adenovirus infection, Conjunctivitis, Cough, Ear pain, Headache
Clinical narrative: My son's cold symptoms started on 12/14/2022 in the morning around 8:00AM. He had cough, congestion, and headache. He progressed to complain about ear ache and headache. On 12/16/2022 he woke in the morning with complaining of his eyes and he had a pink eye. On the same day we took him to the doctors office they diagnosed him with Adeno Virus. We gave him over the counter eye drops for 7 days. We did home test for COVID-19 which was negative. On 12/26/2022 we did a PCR for COVID-19 and the results came back on the 12/28/2022 which was negative.
Age: 7.0
Sex: M
Vaccine: COVID19-2
Symptoms: Nasopharyngitis, Respiratory tract congestion, SARS-CoV-2 test negative
Clinical narrative: My son's cold symptoms started on 12/14/2022 in the morning around 8:00AM. He had cough, congestion, and headache. He progressed to complain about ear ache and headache. On 12/16/2022 he woke in the morning with complaining of his eyes and he had a pink eye. On the same day we took him to the doctors office they diagnosed him with Adeno Virus. We gave him over the counter eye drops for 7 days. We did home test for COVID-19 which was negative. On 12/26/2022 we did a PCR for COVID-19 and the results came back on the 12/28/2022 which was negative.
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: 11/13/22 presents to ED for "breathing problem". PMHx of "Parkinson's disease, atrial fibrillation"
Age: 14.0
Sex: M
Vaccine: FLU4
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: 14 year old patient rec'd Fluzone High Dose, no treatment necessary, no adverse reaction.
Age: 10.0
Sex: M
Vaccine: COVID19, HPV9
Symptoms: Axillary pain, Headache, Nausea, Pain in extremity
Clinical narrative: at 6pm on the 11th, his arm started to hurt, which lasted until when he woke up on the 13th. at 10am on the 12th, he got a headache and nausea, which lasted until when he woke up on the 13th. at 10:30 on the 12th, I gave him Tylenol and Zofran. at 9pm on the 12th, he got a pain in his underarm, which lasted until when he woke up on the 13th.
Age: 11.0
Sex: M
Vaccine: COVID19-2
Symptoms: Axillary pain, Headache, Nausea, Sleep disorder
Clinical narrative: Since he's had troubles before, I gave him prophylactic Tylenol and Zofran at the time of the shot. at 9am on the 8th, he got a headache and nausea. I gave him Tylenol and Zofran. The headache lasted until 3:30pm on the 9th. The nausea lasted until 7pm on the 10th. at 7am on the 9th, he got a pain in his underarm. I gave him Tylenol and Zofran. The underarm pain lasted until 7pm on the 10th. at 4am on the 10th, the nausea was so bad that it woke him up. I gave him Zofran at 7am and noon on the 10th.
Age: 49.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Hypersensitivity
Clinical narrative: at 11:30am on the 11th, I got a headache, which got slightly better by 12:45 on the 13th and went away at 9pm on the 13th. at 9:30pm on the 11th, I got sensitive all over. This got even worse at 9am on the 12th, then got slightly better by 12:45pm on the 13th and went away at 9pm on the 13th.
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Fatigue, Headache, Pain, Pyrexia
Clinical narrative: I started having body aches and a light headache and fatigue. My wife was feeling really sick 24 hour prior to myself. I was out of town and waited until we got back home then tested and was positive. I do believe I also had a slight fever. After testing positive for COVID-19 along with my wife we contacted my son that is a HCP and he prescribed PAXLOVID. The medicine did work and the only symptom I had left was the fatigue that lasted for a week or more. In early November I was part of an experimental vaccine.
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I started having body aches and a light headache and fatigue. My wife was feeling really sick 24 hour prior to myself. I was out of town and waited until we got back home then tested and was positive. I do believe I also had a slight fever. After testing positive for COVID-19 along with my wife we contacted my son that is a HCP and he prescribed PAXLOVID. The medicine did work and the only symptom I had left was the fatigue that lasted for a week or more. In early November I was part of an experimental vaccine.
Age: 49.0
Sex: F
Vaccine: COVID19-2
Symptoms: Headache, Hyperaesthesia, Hyperhidrosis, Mobility decreased, Pain in extremity
Clinical narrative: at 8pm on the 2nd, my arm started to hurt, which lasted until the 5th. at 9pm on the 2nd, i got a headache, which lasted until the 5th. at 8am on the 3rd, my arm movement was impared, and I was feeling groggy, both of which lasted until the 5th. at 11am on the 3rd, I was feeling sensitive, which lasted until the 5th. at 8am on the 4th, everything above was less intense but still there, and I got sweaty, which lasted until the 5th.
Age: 49.0
Sex: F
Vaccine: COVID19-2
Symptoms: Somnolence
Clinical narrative: at 8pm on the 2nd, my arm started to hurt, which lasted until the 5th. at 9pm on the 2nd, i got a headache, which lasted until the 5th. at 8am on the 3rd, my arm movement was impared, and I was feeling groggy, both of which lasted until the 5th. at 11am on the 3rd, I was feeling sensitive, which lasted until the 5th. at 8am on the 4th, everything above was less intense but still there, and I got sweaty, which lasted until the 5th.
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product administered to patient of inappropriate age
Clinical narrative: Patient received 0.2mL of Pfizer purple cap COVID-19 vaccine. Patient's age was 10 years at the time and date of the incident and was outside the EUA for the Pfizer purple cap COVID-19 vaccine.   Clinic staff were not aware of this event until State notified clinic staff that state documentation review showed adult dose was documented in a pediatric immunization record.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, C-reactive protein increased, COVID-19, Chest X-ray normal, Chronic obstructive pulmonary disease
Clinical narrative: Patient is a 56 y.o. female patient of DO pmh copd, htn who presents to ED with shortness of breath and cough for the past 2 days   Acute respiratory failure with hypoxia  Influenza A and Covid-19 infection Acute COPD exacerbation Pt with symptoms for 2 days, pleuritic chest pain, cough, shortness of breath, fever, nausea Hypoxic to 85% requiring 2 to 3LNC on adm, now weaning to 2L and sats 94% CRP 100.8. procal normal Date of onset of symptoms: 12/5/22, Date of covid positive test: 12/7/22 fully vaccinated per patient (no booster) CXR no acute findings ID consulted, started remdesevir; given 1 dose of Tocilizumab 12/8 Started tamiflu, and dexamethasone Cont albuterol inhalers.  Patient weaned to room air 12/9 AM, requesting discharge home Recommend follow-up with PCP   Leukopenia Wbc 3.08, mcv 86.9, suspect viral infections contributing follow   Tobacco abuse She has smoked 2 ppd for over 30 years   Essential htn Bp controlled continue losartan, follow   OSA Does not use cpap at home currently   Anxiety and depression Home meds continued   Chronic pain Continue prn percocet   GERD Continue ppi  Morbid obesity with Prediabetes 8/3/22 hgba1c 5.7   BMI 47 Diet and exercise when able
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Cough, Dyspnoea, Glycosylated haemoglobin normal, Influenza
Clinical narrative: Patient is a 56 y.o. female patient of DO pmh copd, htn who presents to ED with shortness of breath and cough for the past 2 days   Acute respiratory failure with hypoxia  Influenza A and Covid-19 infection Acute COPD exacerbation Pt with symptoms for 2 days, pleuritic chest pain, cough, shortness of breath, fever, nausea Hypoxic to 85% requiring 2 to 3LNC on adm, now weaning to 2L and sats 94% CRP 100.8. procal normal Date of onset of symptoms: 12/5/22, Date of covid positive test: 12/7/22 fully vaccinated per patient (no booster) CXR no acute findings ID consulted, started remdesevir; given 1 dose of Tocilizumab 12/8 Started tamiflu, and dexamethasone Cont albuterol inhalers.  Patient weaned to room air 12/9 AM, requesting discharge home Recommend follow-up with PCP   Leukopenia Wbc 3.08, mcv 86.9, suspect viral infections contributing follow   Tobacco abuse She has smoked 2 ppd for over 30 years   Essential htn Bp controlled continue losartan, follow   OSA Does not use cpap at home currently   Anxiety and depression Home meds continued   Chronic pain Continue prn percocet   GERD Continue ppi  Morbid obesity with Prediabetes 8/3/22 hgba1c 5.7   BMI 47 Diet and exercise when able
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Leukopenia, Mean cell volume normal, Nausea, Pleuritic pain, Procalcitonin normal
Clinical narrative: Patient is a 56 y.o. female patient of DO pmh copd, htn who presents to ED with shortness of breath and cough for the past 2 days   Acute respiratory failure with hypoxia  Influenza A and Covid-19 infection Acute COPD exacerbation Pt with symptoms for 2 days, pleuritic chest pain, cough, shortness of breath, fever, nausea Hypoxic to 85% requiring 2 to 3LNC on adm, now weaning to 2L and sats 94% CRP 100.8. procal normal Date of onset of symptoms: 12/5/22, Date of covid positive test: 12/7/22 fully vaccinated per patient (no booster) CXR no acute findings ID consulted, started remdesevir; given 1 dose of Tocilizumab 12/8 Started tamiflu, and dexamethasone Cont albuterol inhalers.  Patient weaned to room air 12/9 AM, requesting discharge home Recommend follow-up with PCP   Leukopenia Wbc 3.08, mcv 86.9, suspect viral infections contributing follow   Tobacco abuse She has smoked 2 ppd for over 30 years   Essential htn Bp controlled continue losartan, follow   OSA Does not use cpap at home currently   Anxiety and depression Home meds continued   Chronic pain Continue prn percocet   GERD Continue ppi  Morbid obesity with Prediabetes 8/3/22 hgba1c 5.7   BMI 47 Diet and exercise when able
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, White blood cell count decreased
Clinical narrative: Patient is a 56 y.o. female patient of DO pmh copd, htn who presents to ED with shortness of breath and cough for the past 2 days   Acute respiratory failure with hypoxia  Influenza A and Covid-19 infection Acute COPD exacerbation Pt with symptoms for 2 days, pleuritic chest pain, cough, shortness of breath, fever, nausea Hypoxic to 85% requiring 2 to 3LNC on adm, now weaning to 2L and sats 94% CRP 100.8. procal normal Date of onset of symptoms: 12/5/22, Date of covid positive test: 12/7/22 fully vaccinated per patient (no booster) CXR no acute findings ID consulted, started remdesevir; given 1 dose of Tocilizumab 12/8 Started tamiflu, and dexamethasone Cont albuterol inhalers.  Patient weaned to room air 12/9 AM, requesting discharge home Recommend follow-up with PCP   Leukopenia Wbc 3.08, mcv 86.9, suspect viral infections contributing follow   Tobacco abuse She has smoked 2 ppd for over 30 years   Essential htn Bp controlled continue losartan, follow   OSA Does not use cpap at home currently   Anxiety and depression Home meds continued   Chronic pain Continue prn percocet   GERD Continue ppi  Morbid obesity with Prediabetes 8/3/22 hgba1c 5.7   BMI 47 Diet and exercise when able
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Exposure to SARS-CoV-2, Feeling abnormal, Headache
Clinical narrative: I started feeling a little under the weather at the time my daughter and granddaughter had COVID-19 so I decided to take a COVID test. I started feeling sluggish, coughing, no fever and a headache cooled off and it helped with the cough. I went to urgent care and was prescribed a course of PAXLOVID that I will be taking for the next five days.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Sluggishness
Clinical narrative: I started feeling a little under the weather at the time my daughter and granddaughter had COVID-19 so I decided to take a COVID test. I started feeling sluggish, coughing, no fever and a headache cooled off and it helped with the cough. I went to urgent care and was prescribed a course of PAXLOVID that I will be taking for the next five days.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Oropharyngeal pain, Respiratory tract congestion
Clinical narrative: I received my Covid -19 vaccine on 09/29/2022. On 12/10/2022 I tested positive for Covid-19. On 12/09/2022 in the afternoon i felt sluggish, sore throat, and congestion. On the 10 symptoms gotten worse and I started to cough.  As the days progressed the symptoms got worse with added trouble breathing. I contacted my doctor and was prescribed medication. After five days I went and had another apt and was still having symptoms and was prescribed steroids for my lungs. After 6 days I did start feeling better.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sluggishness
Clinical narrative: I received my Covid -19 vaccine on 09/29/2022. On 12/10/2022 I tested positive for Covid-19. On 12/09/2022 in the afternoon i felt sluggish, sore throat, and congestion. On the 10 symptoms gotten worse and I started to cough.  As the days progressed the symptoms got worse with added trouble breathing. I contacted my doctor and was prescribed medication. After five days I went and had another apt and was still having symptoms and was prescribed steroids for my lungs. After 6 days I did start feeling better.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Disturbance in attention, Headache, Impaired quality of life, Memory impairment, Mobility decreased
Clinical narrative: During the night following my second dose of the Pfizer COVID-19 vaccination, I experienced a severe, debilitating headache that left me bed-bound and unable to get up for the entire night. I had never experienced a headache so severe in my life. In the months that followed, I continued to experience recurrent headaches (albeit more mild) which had not occurred in my life prior to vaccination, though by now these have largely subsided. However, following vaccination (and beginning essentially following the severe headache I experienced after my second dose) I also developed prolonged short term and working memory deficits, reduced problem solving ability, and concentration deficits which I had also not experienced prior to vaccination, and which now remain incompletely recovered and effect my quality of life.  I have not yet seen a healthcare professional regarding this issue, as I had held hope that I would recover fully, though now that it has persisted I will be doing so.
Age: 8.0
Sex: F
Vaccine: FLU4
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: 9 year old patient rec'd Fluzone High Dose, no treatment necessary, no adverse reaction.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive, Throat irritation
Clinical narrative: It started with a runny nose and scratchy throat that turned into a sore throat. I started Paxlovid on 12/26 and I'm fine today. It lasted 4 days.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling of body temperature change, Insomnia, Lung disorder, Malaise
Clinical narrative: Trembling and shivering while trying to fall asleep, tingling on only the side of my body that got the vaccine, feeling hot and cold, was sick for the rest of the year
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Tremor
Clinical narrative: Trembling and shivering while trying to fall asleep, tingling on only the side of my body that got the vaccine, feeling hot and cold, was sick for the rest of the year
Age: 55.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Dyspnoea, Fatigue, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Had hard time breathing and was congested and fatigued; Took a home COVID-19 test and it was positive; Contacted doctor and was prescribed PAXLOVID; Took another home COVID-19 test 2 weeks later and was negative.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, COVID-19, Chronic obstructive pulmonary disease, Condition aggravated, Dyspnoea
Clinical narrative: Patient brought in to the ED by EMS on 10/30 for shortness of breath and weakness. EMS found patient to have 90-92 SpO2 on room air and was placed on 3L O2 by nasal cannula. In the ED, patient tested positive for COVID-19 by PCR. She was admitted 10/30-10/31 and diagnosed with hypoxia related to COPD exacerbation/COVID-19 infection. Her O2 requirements gradually ame down and was able to be on room air by 10/31.  She has received the primary COVID vaccine series and one booster.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypoxia, SARS-CoV-2 test positive
Clinical narrative: Patient brought in to the ED by EMS on 10/30 for shortness of breath and weakness. EMS found patient to have 90-92 SpO2 on room air and was placed on 3L O2 by nasal cannula. In the ED, patient tested positive for COVID-19 by PCR. She was admitted 10/30-10/31 and diagnosed with hypoxia related to COPD exacerbation/COVID-19 infection. Her O2 requirements gradually ame down and was able to be on room air by 10/31.  She has received the primary COVID vaccine series and one booster.
Age: 15.0
Sex: F
Vaccine: FLU4
Symptoms: Incorrect dose administered, No adverse event, Product administered to patient of inappropriate age
Clinical narrative: 15 year old patient rec'd Fluzone High Dose, no treatment necessary, no adverse reaction.
Age: 50.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Feeling abnormal, No adverse event, Oropharyngeal pain, Respiratory tract congestion
Clinical narrative: I did not have an adverse reaction to the vaccine. On 12/16/2022 I started feeling symptoms of sore throat and congestion. On 12/18/2022 I tested positive for COVID-19 at the urgent care. I was advised to take regular cold like over the counter medication. As of today, I have a little brain fog and congestion.
Age: 50.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I did not have an adverse reaction to the vaccine. On 12/16/2022 I started feeling symptoms of sore throat and congestion. On 12/18/2022 I tested positive for COVID-19 at the urgent care. I was advised to take regular cold like over the counter medication. As of today, I have a little brain fog and congestion.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: COVID-19, Cough, Fatigue, Headache, Myalgia
Clinical narrative: This is a COVID breakthrough report - requested by CDC by phone call. I'm vacinated 2 course Moderna, 2 booters and a 3 bivalent booster just 2 months prior to contracting Covid.  First symptom (11/17/22) was a sore throat, followed by nasal congestion. Started intermittent dry coughing day 2. I felt like I had a cold for 3-4 days. Sore throat would resolve then return 3 times. I was tired, head and muscle aches. The 3rd time my tonsils were swollen so I went to urgent care (11/25/22) to get them checked out. Was told my lungs sounded clear. Took over the counter meds for the sinusitis. I never had a fever. Tested positive until 12/5/22
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: Nasal congestion, Nasopharyngitis, Oropharyngeal pain, SARS-CoV-2 test positive, Sinusitis
Clinical narrative: This is a COVID breakthrough report - requested by CDC by phone call. I'm vacinated 2 course Moderna, 2 booters and a 3 bivalent booster just 2 months prior to contracting Covid.  First symptom (11/17/22) was a sore throat, followed by nasal congestion. Started intermittent dry coughing day 2. I felt like I had a cold for 3-4 days. Sore throat would resolve then return 3 times. I was tired, head and muscle aches. The 3rd time my tonsils were swollen so I went to urgent care (11/25/22) to get them checked out. Was told my lungs sounded clear. Took over the counter meds for the sinusitis. I never had a fever. Tested positive until 12/5/22
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: Tonsillar hypertrophy, Vaccine breakthrough infection
Clinical narrative: This is a COVID breakthrough report - requested by CDC by phone call. I'm vacinated 2 course Moderna, 2 booters and a 3 bivalent booster just 2 months prior to contracting Covid.  First symptom (11/17/22) was a sore throat, followed by nasal congestion. Started intermittent dry coughing day 2. I felt like I had a cold for 3-4 days. Sore throat would resolve then return 3 times. I was tired, head and muscle aches. The 3rd time my tonsils were swollen so I went to urgent care (11/25/22) to get them checked out. Was told my lungs sounded clear. Took over the counter meds for the sinusitis. I never had a fever. Tested positive until 12/5/22
Age: 78.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Feeling abnormal, Headache, Influenza like illness, Mobility decreased
Clinical narrative: On the 19th I began feeling something wasn't right. I had a foggy feeling in the head and increased congestion. That morning I had sore throat and heavy flu like symptoms with heavy congestion, headache and phlegm in my throat. I did not want to get out of bed. I used a at home test kit, and it was positive on 12/20/2022. I contacted my PCP, that morning I was not offered any medications for my symptoms. The person in the office called me back with a reference to the local treatment center that was not helpful and 4 and a half hours later they called me back. I decided to go to an urgent care instead and was retested and received a prescribed PAXLOVID. I am finished with the doses, and I tested negative on 12/26/2022. I feel okay.
Age: 78.0
Sex: M
Vaccine: COVID19-2
Symptoms: Oropharyngeal pain, Productive cough, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: On the 19th I began feeling something wasn't right. I had a foggy feeling in the head and increased congestion. That morning I had sore throat and heavy flu like symptoms with heavy congestion, headache and phlegm in my throat. I did not want to get out of bed. I used a at home test kit, and it was positive on 12/20/2022. I contacted my PCP, that morning I was not offered any medications for my symptoms. The person in the office called me back with a reference to the local treatment center that was not helpful and 4 and a half hours later they called me back. I decided to go to an urgent care instead and was retested and received a prescribed PAXLOVID. I am finished with the doses, and I tested negative on 12/26/2022. I feel okay.
Age: 78.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Angiogram pulmonary normal, Anxiety, Bacterial test positive, Blood culture
Clinical narrative: 78 y.o. male patient with history of UTIs, T2DM, paroxysmal atrial fibrillation, DVT, PAD, HTN, urinary incontinence, depression and anxiety who presented with anxiety and fever, found to have respiratory failure, COVID-19, severe sepsis and acute ESBL UTI. He was treated with steroids and was weaned off of O2 prior to discharge. He was treated with Ertapenem for 3 days until urine culture returned with typical E. Coli s/t Bactrim (same as before) and ID recommended that he finish 14 total days of Bactrim.    Acute hypoxic respiratory failure -- resovled COVID-19 Virus Infection Date of onset of symptoms: 7 days prior to admission Symptoms present on admission: nausea, fever, diarrhea, cough Date of covid positive test: 11/29 Vaccination status: vaccinated CXR (reviewed personally): No acute pulmonary findings CTPA: No evidence of PE or acute pulmonary abnormality Oxygen requirements on admission: 3-4L NC in ED Current oxygen requirements: RA Medical therapy: steroids x10d, out of window for remdesivir (already took Paxlovid) Consultants following: Infectious Disease Anticipated special isolation end date: 12/8/22   Severe Sepsis, POA -- resolved Urinary Tract Infection Hx of ESBL E. Coli Hx of Pyelonephritis Patient febrile (101.8), tachypneic, with leukocytosis on admission Likely sources include UTI and COVID-19 pneumonia LA 4.4 on admission UA positive nitrite, large leukocyte esterase, 122 WBCs, >180 RBCs, many bacteria Blood cultures pending, urine cultures with ESBL E. Coli ID consulted -- PO Bactrim through 12/10   Type 2 Diabetes, Insulin Dependent A1c of 8.7 on 10/24/22 Home regimen 30u lantus nightly with SSI Continued on admission   Urinary Incontinence Likely due to radiation after prostate cancer treatment Follows with doctor Home solifenacin 10mg daily  Paroxysmal Atrial Fibrillation EKG with NSR Continue home BB and restart apixaban (especially in light of COVID infection) Pt will f/u with doctor to discuss further   Peripheral Arterial Disease Hx of DVT Continue home lipitor, plavix Restarted apixaban as above   HTN Continue home lisinopril, hydrochlorothiazide, toprol   Anxiety/Depression Continue home buspar, cymbalta, ativan PRN